<http://www.wikidata.org/entity/Q65391095>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P6099>	<http://www.wikidata.org/entity/Q42824440> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P1132>	"105"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P6099>	<http://www.wikidata.org/entity/statement/Q65391095-216E495C-AB46-473B-BC37-A9FBFCBE73EF> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P580>	<http://www.wikidata.org/entity/statement/Q65391095-B40A1562-FE1E-4195-A224-F748237638B4> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q7370121> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q5188247> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.w3.org/2000/01/rdf-schema#label>	"Study of Mapatumumab in Combination With Bortezomib"@nl .
<http://www.wikidata.org/entity/Q65391095>	<http://schema.org/description>	"clinical trial"@en .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q16> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma"@en .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q65391095-6DF65D98-7A9E-498C-9B87-FED62692CB55> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q65391095-76FDB1F2-AF18-4E55-AD8E-1088182EF0C6> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P8363>	<http://www.wikidata.org/entity/statement/Q65391095-8BE008BD-695C-41D6-A684-8C5DA3444E26> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q65391095-503D8E13-5D86-47D6-A567-E9CF3F3C827F> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q15179382> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P8363>	<http://www.wikidata.org/entity/Q78089383> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P1476>	"A Phase 2, Multi-Center, Open-Label, Randomized Study of Mapatumumab (TRM-1 [HGS1012], a Fully Human Monoclonal Antibody to TRAIL-R1) in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma"@en .
<http://www.wikidata.org/entity/Q65391095>	<http://schema.org/description>	"klinisch onderzoek"@nl .
<http://www.wikidata.org/entity/Q65391095>	<http://schema.org/description>	"ensayu cl\u00EDnicu"@ast .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P580>	"2006-05-01T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q65391095-B5AC10B9-6C7F-4709-8A52-A5267DE2A68D> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P582>	<http://www.wikidata.org/entity/statement/Q65391095-349B5125-3FBD-4DC8-BA04-33CDA8BE07C4> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P2899>	"18"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q30612> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P3098>	<http://www.wikidata.org/entity/statement/Q65391095-923E68E0-064E-4710-AC4E-AA74B3DF6F89> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q668> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q65391095-13FF0D6D-08DA-4DFC-9085-17F83926CBD0> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q30> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P1132>	<http://www.wikidata.org/entity/statement/Q65391095-8431E820-A4EE-4DB3-8CB4-8CEC396DF6CC> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.w3.org/2000/01/rdf-schema#label>	"Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma"@en .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q408> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q65391095-89ED817E-1B4B-4D39-9041-CFF81042F008> .
<http://www.wikidata.org/entity/Q65391095>	<http://schema.org/description>	"\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P582>	"2010-10-01T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P2899>	<http://www.wikidata.org/entity/statement/Q65391095-38D19CD3-1E26-4666-8BD9-15E6C3609B8F> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q65391095-E45CFE8E-4391-4FF0-8E56-42F3E189035E> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Study of Mapatumumab in Combination With Bortezomib"@nl .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q131252> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q65391095-39DFA3D5-0AF4-48EE-AEE3-824FFB6C5D97> .
<http://www.wikidata.org/entity/Q65391095>	<http://schema.org/name>	"Study of Mapatumumab in Combination With Bortezomib"@nl .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q65391095-44C55C50-72AB-4BE1-9728-4A2A9B26425A> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P1050>	<http://www.wikidata.org/entity/Q467635> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/direct/P3098>	"NCT00315757" .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q65391095-5DDEAFE9-7B50-4C50-9DEF-9F15E9B2892B> .
<http://www.wikidata.org/entity/Q65391095>	<http://www.wikidata.org/prop/P1050>	<http://www.wikidata.org/entity/statement/Q65391095-E481538E-787F-4D18-A0A9-3E5C087F5069> .
<http://www.wikidata.org/entity/Q65391095>	<http://schema.org/name>	"Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma"@en .